Beneficial effects of melatonin in cardiovascular disease (Q37747491)

22 August 2017

1 reference

title

Beneficial effects of melatonin in cardiovascular disease (English)

1 reference

22 August 2017

0 references

cardiovascular disease

1 reference

4

Lorena Fuentes-Broto

1 reference

22 August 2017

1

Russel J Reiter

1 reference

22 August 2017

2

Dun-Xian Tan

1 reference

22 August 2017

Sergio D Paredes

3

1 reference

PubMed ID

20455793

22 August 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

22 August 2017

1 reference

22 August 2017

42

1 reference

22 August 2017

276-285

1 reference

22 August 2017

4

1 reference

Functional MT1 and MT2 melatonin receptors in mammals

22 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

A Review of the Multiple Actions of Melatonin on the Immune System

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

NRH:quinone reductase 2: an enzyme of surprises and mysteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin as a cytoskeletal modulator: implications for cell physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin and circadian rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Therapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Coexpression of the melatonin receptor 1 and nestin in human breast cancer specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin, mitochondrial homeostasis and mitochondrial-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

The chemistry of melatonin's interaction with reactive species

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Evidence supporting the use of melatonin in short gestation infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin and the ovary: physiological and pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Smith-Magenis syndrome: a case report of improved sleep after treatment with beta1-adrenergic antagonists and melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin as a potential antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Experimental hypertension in pinealectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Human melatonin production decreases with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

The pineal gland and melatonin in relation to aging: a summary of the theories and of the data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Sleep actigraphy in hypertensive patients with the 'non-dipper' blood pressure profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Cardiovascular protection and blood pressure reduction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin, sleep, and circadian rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Prolonged melatonin administration decreases nocturnal blood pressure in women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Renal artery stenosis: a common, treatable cause of renal failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Effects of melatonin on blood pressure in stress-induced hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Participation of the anterior hypothalamus in the baroreceptor reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Expression of the MT1 melatonin receptor subtype in human coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Oxidative stress and cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin combats molecular terrorism at the mitochondrial level

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Biomarkers of atherosclerotic plaque instability and rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Effect of melatonin and metabolites on copper-mediated oxidation of flow density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin protects against oxidized low-density lipoprotein-induced inhibition of nitric oxide production in human umbilical artery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin treatment in peri- and postmenopausal women elevates serum high-density lipoprotein cholesterol levels without influencing total cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

Melatonin: reducing the toxicity and increasing the efficacy of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890903485748

10.3109/07853890903485748

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20455793